Stem Cells Spin S.A. (WSE:SCS)

Stem Cells Spin Statistics

Total Valuation

Stem Cells Spin has a market cap or net worth of PLN 15.05 million. The enterprise value is 15.21 million.

Market Cap	15.05M
Enterprise Value	15.21M

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Stem Cells Spin has 41.34 million shares outstanding.

Current Share Class	39.64M
Shares Outstanding	41.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.72%
Owned by Institutions (%)	n/a
Float	22.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	130.01
PB Ratio	2.30
P/TBV Ratio	2.31
P/FCF Ratio	n/a
P/OCF Ratio	4.64
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.62, with an EV/FCF ratio of -342.12.

EV / Earnings	-29.77
EV / Sales	131.42
EV / EBITDA	11.62
EV / EBIT	n/a
EV / FCF	-342.12

Financial Position

The company has a current ratio of 7.10, with a Debt / Equity ratio of 0.03.

Current Ratio	7.10
Quick Ratio	0.67
Debt / Equity	0.03
Debt / EBITDA	0.13
Debt / FCF	-3.95
Interest Coverage	-133.69

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-7.51%
Return on Capital Employed (ROCE)	-5.15%
Weighted Average Cost of Capital (WACC)	6.72%
Revenue Per Employee	115,736
Profits Per Employee	-510,920
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +89.72% in the last 52 weeks. The beta is 0.46, so Stem Cells Spin's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+89.72%
50-Day Moving Average	0.39
200-Day Moving Average	0.32
Relative Strength Index (RSI)	43.96
Average Volume (20 Days)	1,789

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stem Cells Spin had revenue of PLN 115,736 and -510,920 in losses. Loss per share was -0.01.

Revenue	115,736
Gross Profit	105,391
Operating Income	-506,569
Pretax Income	-510,920
Net Income	-510,920
EBITDA	1.31M
EBIT	-506,569
Loss Per Share	-0.01

Balance Sheet

The company has 12,348 in cash and 175,704 in debt, with a net cash position of -163,356 or -0.00 per share.

Cash & Cash Equivalents	12,348
Total Debt	175,704
Net Cash	-163,356
Net Cash Per Share	-0.00
Equity (Book Value)	6.53M
Book Value Per Share	0.16
Working Capital	607,493

Cash Flow

In the last 12 months, operating cash flow was 3.24 million and capital expenditures -3.29 million, giving a free cash flow of -44,458.

Operating Cash Flow	3.24M
Capital Expenditures	-3.29M
Free Cash Flow	-44,458
FCF Per Share	-0.00

Margins

Gross Margin	91.06%
Operating Margin	-437.69%
Pretax Margin	-441.45%
Profit Margin	n/a
EBITDA Margin	1,131.03%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Stem Cells Spin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.40%
FCF Yield	-0.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stem Cells Spin has an Altman Z-Score of 1.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.68
Piotroski F-Score	3